$167.72 meals Payment -- Allergan (AbbVie) to Dr. Joseph Carter
Allergan (AbbVie) provides $167.72 meal to Plastic Surgeon Joseph Carter for Jardiance.
This page provides a detailed analysis of a $167.72 meals payment from Allergan (AbbVie) to Dr. Joseph Carter. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $167.72 |
| Payment Type | meals |
| Payment Nature | Food and Beverage |
| Pharmaceutical Company | Allergan (AbbVie) |
| Physician | Dr. Joseph Carter |
| NPI Number | 1486523366 |
| Physician Specialty | Plastic Surgery |
| Location | City, AL |
| Date of Payment | 2025-11-01 |
| Related Drug/Device | Jardiance |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Allergan (AbbVie) made a $167.72 meals payment to Joseph Carter, a Plastic Surgery specialist in City, AL. The payment was associated with Jardiance. The payment of $167.72 was for meals provided by Allergan (AbbVie) to Dr. Joseph Carter. This meal expense is associated with the drug Jardiance, indicating a potential educational or promotional context. The payment occurred on November 1, 2025, and was processed through the CMS Open Payments system.
Patient Guidance: What This Payment Means for You
This record indicates a meal provided by a pharmaceutical company, which is a common practice. It's important to consider if such interactions influence prescribing habits. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Meals provided by pharmaceutical companies to physicians are common across many specialties. The amount of this meal payment is likely within typical ranges for such interactions.
Regulatory Context: Sunshine Act Requirements
Payments made by pharmaceutical manufacturers to physicians are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to promote transparency in healthcare.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- meals-and-entertainment
- physician-interactions
- drug-promotion
- open-payments
- allergan-abbvie
- jardiance
Understanding meals Payments
Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.
Frequently Asked Questions About This Payment
What was this $167.72 payment for?
This was a meals payment of $167.72 from Allergan (AbbVie) to Joseph Carter, categorized as "Food and Beverage". It was associated with Jardiance. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Joseph Carter accept pharmaceutical money?
Yes, Joseph Carter received this $167.72 payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Joseph Carter's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this meals payment?
A meals payment of $167.72 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Plastic Surgery?
To compare this payment against Plastic Surgery averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Plastic Surgery physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Joseph Carter's relationship with Allergan (AbbVie)?
The payment amount is relatively small, suggesting a routine interaction rather than a significant financial incentive. This $167.72 meals payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Plastic Surgery?
The payment type is 'meals', which is a common form of interaction between pharmaceutical companies and healthcare providers.
What should patients do after learning about this payment?
This record indicates a meal provided by a pharmaceutical company, which is a common practice. It's important to consider if such interactions influence prescribing habits.
What else should I know about this meals payment?
The specific drug mentioned is Jardiance, which may or may not be directly related to the specialty of Plastic Surgery.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.